The stated reason for the layoff is the CRL for CHRS' Neulasta FoB (#msg-132094293, #msg-132098831), but the delay in submitting the BLA for CHRS' Humira FoB (#msg-132511112) surely has something to do with it too.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”